Home Heart Transplant Heart Transplant Rejection: Pipeline Review (H1 2018) Featuring Astellas Pharma, Heat Biologics, Noxxon Pharma ...

Heart Transplant Rejection: Pipeline Review (H1 2018) Featuring Astellas Pharma, Heat Biologics, Noxxon Pharma ...

3 min read

DUBLIN--(BUSINESS WIRE)--The "Heart
Transplant Rejection - Pipeline Review, H1 2018"
drug pipelines
has been added to ResearchAndMarkets.com's offering.

This latest Pharmaceutical and Healthcare disease pipeline guide
provides an overview of the Heart Transplant Rejection (Immunology)
pipeline landscape.

The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest
news and press releases.

Heart Transplant Rejection (Immunology) pipeline guide helps in
identifying and tracking emerging players in the market and their
portfolios, enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage.

Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.

Scope

  • The pipeline guide provides a snapshot of the global therapeutic
    landscape of Heart Transplant Rejection (Immunology).
  • The pipeline guide reviews pipeline therapeutics for Heart Transplant
    Rejection (Immunology) by companies and universities/research
    institutes based on information derived from company and
    industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of
    development ranging from pre-registration till discovery and
    undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline
    products which comprise, product description, descriptive licensing
    and collaboration details, R&D brief, MoA & other developmental
    activities.
  • The pipeline guide reviews key companies involved in Heart Transplant
    Rejection (Immunology) therapeutics and enlists all their major and
    minor projects.
  • The pipeline guide evaluates Heart Transplant Rejection (Immunology)
    therapeutics based on mechanism of action (MoA), drug target, route of
    administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued
    pipeline projects.
  • The pipeline guide reviews latest news related to pipeline
    therapeutics for Heart Transplant Rejection (Immunology)

Companies Featured

  • Astellas Pharma Inc.
  • Heat Biologics Inc.
  • Noxxon Pharma AG
  • TxCell SA

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/c7qdk6/heart_transplant?w=4

Source link

Check Also

Staying healthy into old age may be directly linked to this food, researchers find

Regular exercise and a well-balanced diet can help you maintain your health as you age. Bu…